Genitourinary Cancer Pembrolizumab Monotherapy for Unresponsive NMIBC: Keynote-057 Cohort B Results Mar 15, 2023
Genitourinary Cancer Quality of Life Assessment in IL-15RαFc N-803 + BCG for BCG-Unresponsive NMIBC Patients in QUILT 3.032 Mar 15, 2023
Genitourinary Cancer Primary Analysis: Sacituzumab Govitecan in Ineligible mUC for Platinum Therapy Mar 15, 2023
Genitourinary Cancer Elderly Metastatic Prostate Cancer: PEACE-1 Study on Abiraterone Therapy Mar 15, 2023
Genitourinary Cancer Efficacy and Safety of Darolutamide in ARASENS by Disease Volume and Risk: Phase 3 Study Mar 15, 2023
